½ÃÀ庸°í¼­
»óǰÄÚµå
1631003

³Ãµ¿¿ä¹ý ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Cryotherapy Market Size, Share & Trends Analysis Report By Product (Cryochambers, Cryosaunas), By Application (Pain Management, Beauty & Wellness), By End Use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, IncÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 3¾ï 2,530¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2025-2030³âÀÇ CAGRÀº 7.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ¼ºÀåÀº ÇÇÆ®´Ï½º, ¹Ì¿ë ¹× À£ºù¿¡¼­ µ¿°á ¿ä¹ý ¼ö¿ä Áõ°¡, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ ¹× ³·Àº ħ½À Ä¡·áÀÇ ³ôÀº ¼ö¿ä ¶§¹®ÀÔ´Ï´Ù. ¸¸¼º ÁúȯÀÇ Ä¡·á¸¦ À§ÇÑ ³·Àº ħ½À Ä¡·á ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ³Ãµ¿ ¼ö¼úÀº ³·Àº ħ½À ¼ö¼úÀÔ´Ï´Ù. ±âÁ¸ÀÇ ¼ö¼ú¿¡ ºñÇØ ÅëÁõÀÌ Àû°í, »óó Ä¡À¯°¡ ºü¸£°í, ¼ö¼úâÀÌ Àû°í, ÀÔ¿ø ±â°£ÀÌ Âª°í, ÇÕº´ÁõÀÇ À§ÇèÀÌ ³·À½ µî ´Ù¾çÇÑ ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù.

¾Æ½ºÅ¬·¹ÇÇ¿À½º ÀåũƮ °Ô¿À¸£±×ÀÇ Ä®µð¿À Ŭ¸®´ÐÀº µ¶ÀÏ¿¡¼­µµ À¯¼öÀÇ ½ÉÀå ¼¾ÅÍÀÌ¸ç ¸Å³â ¾à 300°ÇÀÇ ½ÉÀå ³Ãµ¿ ÀýÁ¦ ¼ö¼úÀ» ½Ç½ÃÇϰí ÀÖ´Ù°í ÇÕ´Ï´Ù. ÇÇÆ®´Ï½º, ¹Ì¿ë, À£ºù Ä¡·á´Â ³Ãµ¿ ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù. ½ºÆ÷Ã÷ ºÎ»óÀÇ ¹ß»ý·üÀÌ ³ô±â ¶§¹®¿¡ ÀϺΠ½ºÆ÷Ã÷ Ŭ·´°ú ½ºÆ÷Ã÷ ÆÀÀº »óÇØÀÇ Á¶±â ȸº¹À» À§ÇØ Å©¶óÀÌ¿Àè¹ö¸¦ »ç¿ëÇÕ´Ï´Ù. ¿¹¸¦ µé¾î µ¶ÀÏÀÇ º¸Æ® ÆÀ, ¿þÀÏÁî ·¯±× ºñÄ¡ µ¼, Áß±¹ ¿Ã¸²ÇÈ ÆÀ µîÀº ÀÚü ³Ãµ¿ è¹ö¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀº ¾ÕÀ¸·Î ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÆÒµ¥¹Í °¡¿îµ¥ ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦¿Í ÆÒµ¥¹Í ¾ïÁ¦¸¦ À§ÇÑ ºÀ¼â ¶§¹®¿¡ ÆÒµ¥¹Í Ãʱ⿡´Â ³Ãµ¿¿ä¹ý ¼ö¿äÀÇ µÐÈ­°¡ °üÂûµÇ¾ú½À´Ï´Ù.

±×·¯³ª ´ëºÎºÐÀÇ ±¹°¡¿¡¼­ 2020³â ¸»±îÁö ½ÃÀåÀº ÆäÀ̽º¸¦ µÇã¾Ò½À´Ï´Ù. ±â¾÷Àº ½ÅÁ¦Ç° °³¹ß ¹× ÆÄÆ®³Ê½Ê°ú °°Àº Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 8¿ù, Cryoport, Inc.´Â ¾à 5,600¸¸ ´Þ·¯ÀÇ Çö±Ý °Å·¡·Î CRYOPDP¸¦ ÀμöÇß½À´Ï´Ù. CRYOPDP´Â ÇÁ¶û½º ÆÄÀÌ¿À´Ï¾î ±â¾÷À¸·Î ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹× ÀÓ»ó ¿¬±¸¸¦ À§ÇØ ¿Âµµ °ü¸®µÈ ¹°·ù ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. 2021³â 10¿ù, CARE Innovative Solutions´Â Slynarski Knee ClinicÀÇ °³¼³À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Å¬¸®´ÐÀº ¹«¸­ °ü·Ã Ä¡·á¿¡ ÄÄÇ»ÅÍ Á¦¾î µ¿°á Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â Æú¶õµå ÃÖÃÊÀÇ Å¬¸®´ÐÀÔ´Ï´Ù.

³Ãµ¿ ¿ä¹ý ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¼ö¼ú ¼ö¿ä Áõ°¡·Î 2024³â¿¡´Â µ¿°á ¼­Á©¸® ºÎ¹®ÀÌ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • Å©¶óÀÌ¿Àè¹ö´Â ¹Ì¿ë Ŭ¸®´Ð°ú ÇÇÆ®´Ï½º ¼¾ÅÍ¿¡¼­ ä¿ëÀÌ ¸¹À¸¸ç ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
  • º¸³Ã°í´Â ÀǾàǰ ÄݵåüÀÎ ¹°·ù¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ 2024³â ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¶ÇÇÑ °ñ¼ö À̽Ä, ü¿Ü¼öÁ¤(IVF), Á¦´ëÇ÷ ÀºÇà µî ÀÇ·á¿ë ÄÝµå ½ºÅ丮ÁöÀÇ ´Ù¾çÇÑ ¿ëµµµµ ÃÖ´ë Á¡À¯À²ÀÇ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
  • ºÏ¹Ì´Â °¡Ã³ºÐ ¼ÒµæÀÌ ³ô°í ÀÇ·á ÀÎÇÁ¶ó°¡ Á¤ºñµÇ¾î ÀÖ¾î 1Àδç ÀÇ·áºñ°¡ ³ô±â ¶§¹®¿¡ Áö¹èÀûÀÎ Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅëÀÇ Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ³Ãµ¿¿ä¹ý ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

  • Á¦Ç° ½ÃÀå Á¡À¯À²(2024³â¡¤2030³â)
  • Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, Á¦Ç°º°(2018-2030³â)
  • Å©¶óÀÌ¿Àè¹ö
  • Å©¶óÀÌ¿À»ç¿ì³ª

Á¦5Àå ³Ãµ¿¿ä¹ý ½ÃÀå : ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ¿ëµµ ½ÃÀå Á¡À¯À²(2024³â¡¤2030³â)
  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ¿ëµµº°(2018-2030³â)
  • ÅëÁõ °ü¸®
  • ¹Ì¿ë°ú °Ç°­
  • ÇÇÆ®´Ï½º
  • ±âŸ

Á¦6Àå ³Ãµ¿¿ä¹ý ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À²(2024³â¡¤2030³â)
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • ³Ãµ¿¿ä¹ý(Å©¶óÀÌ¿À»ç¿ì³ª¿Í Å©¶óÀÌ¿Àè¹ö) ¼¾ÅÍ
  • ½ºÆÄ & ÇÇÆ®´Ï½º ¼¾ÅÍ
  • ±âŸ

Á¦7Àå ³Ãµ¿¿ä¹ý ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â¡¤2030³â)
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®(2018-2030³â)
  • ºÏ¹Ì
    • ±¹°¡º°(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°(2018-2030³â)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
      • °æÀï ÀλçÀÌÆ®
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°(2018-2030³â)
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • Âü°¡ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ/»óÀå ±â¾÷
    • Cryomed
    • Impact Cryotherapy
    • Vacuactivus
    • CryoLiving
    • MECOTEC GmbH
    • CRYO Holding Limited
    • Cryo Innovations
    • CA Manufacturing Sp zoo
    • CryoBuilt, Inc.
    • CRYONiQ
KTH 25.02.28

Cryotherapy Market Growth & Trends:

The global cryotherapy market size is expected to reach USD 325.3 million by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is due to a rise in demand for cryotherapy in fitness, beauty & wellness, increased prevalence of chronic diseases, and the high demand for minimally invasive procedures.A rise in the demand for minimally invasive procedures for the treatment of chronic diseases is also among the primary factors driving the market growth. Cryosurgery is a minimally invasive procedure. It has various advantages over conventional surgeries, including lesser pain, rapid wound healing, minimal surgical wounds, shorter hospital stays, and lower risk of complications.

Cardio Clinic at Asklepios St. Georg, one of the top heart centers in Germany, claims to perform around 300 cardiac cryoablation procedures every year.In fitness, beauty, and wellness treatments, there is a high demand for cryotherapy. Due to the high incidence of sports injuries, several sports clubs and sports teams are using cryo chambers for quicker recovery of injuries. For instance, the German rowing team, Wales Rugby Team, and the Chinese Olympic team have their own cryo chambers. All these factors are anticipated to boost market growth over the coming years. The COVID-19 pandemic adversely affected the market. Amid the pandemic, owing to stringent government regulations and lockdown to control the pandemic, a slowdown in the demand for cryotherapy was observed in the initial phase of the pandemic.

However, the market regained its pace by the end of 2020 in most countries.Companies are adopting strategies, such as new product development and partnerships. For instance, in August 2020, Cryoport, Inc. acquired CRYOPDP in an all-cash transaction of approximately USD 56.0 million. CRYOPDP-a French pioneer company-provides temperature-controlled logistics solutions for cell & gene therapy and clinical research communities. In October 2021, CARE Innovative Solutions announced the launch of the Slynarski Knee Clinic. It is the first clinic in Poland to provide computer-controlled cryotherapy solutions for knee-associated treatments.

Cryotherapy Market Report Highlights:

  • The cryosurgery segment held the largest revenue share in 2024 due to a rise in demand for surgical procedures
  • Cryochamber is expected to grow at a fastest CAGR over the forecast period, due to its high adoption by beauty clinics & fitness centers
  • Cold storage held the largest revenue share in 2024 due to the high demand for pharmaceutical cold chain logistics
  • In addition, various applications of cold storage in healthcare, such as bone marrow transplantation, in vitro fertilization, and cord blood banking, are another factor contributing to its largest share
  • North America is projected to be the dominant region due to high disposable income, well-established healthcare infrastructure, and high per capita healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cryotherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cryotherapy Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cryochambers
    • 4.4.1. Cryochambers Market, 2018 - 2030 (USD Million)
  • 4.5. Cryosaunas
    • 4.5.1. Cryosaunas Market, 2018 - 2030 (USD Million)

Chapter 5. Cryotherapy Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Pain Management
    • 5.4.1. Pain Management Market, 2018 - 2030 (USD Million)
  • 5.5. Beauty & Wellness
    • 5.5.1. Beauty & Wellness Market, 2018 - 2030 (USD Million)
  • 5.6. Fitness
    • 5.6.1. Fitness Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Cryotherapy Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Cryotherapy (Cryosauna and Cryochamber) Centers
    • 6.4.1. Cryotherapy (Cryosauna and Cryochamber) Centers Market, 2018 - 2030 (USD Million)
  • 6.5. Spas & Fitness Centers
    • 6.5.1. Spas & Fitness Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Cryotherapy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Cryotherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Cryotherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • .5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Cryotherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Cryotherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Cryotherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Cryotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Cryomed
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Impact Cryotherapy
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Vacuactivus
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. CryoLiving
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. MECOTEC GmbH
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. CRYO Holding Limited
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Cryo Innovations
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. C A Manufacturing Sp zoo
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. CryoBuilt, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. CRYONiQ
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦